Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...
As economies slow, shoppers pivot toward essentials and value. This article dives into whether walmart recession-proo...
New FEC filings show NAR's RPAC spent more than $10 million across campaigns and committees in 2025-26, with notable ...
As AI moves from model training to real-time inference, one chipmaker looms large for investors. This story explains ...
Investors are weighing growth, profitability, and risk after the newest earnings release. Here’s a practical, plain-l...
Treasury yields are climbing, sending ripples through equities. This piece breaks down why rates are rising, who’s af...
The NEOS Nasdaq-100 High Income ETF (QQQI) shows a 14% headline yield, but most of that payout is return of capital. ...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
As retirees seek steady cash flow, a single Realty Income position could approach $33,000 annually, but concentration...